
Psychopharmacology (Berl). 1999
Oct;146(4):391-9.
Fish EW, Faccidomo S, Miczek KA
Department of Psychology, Tufts University, Medford, Massachusetts, USA.
Rationale: Models of heightened aggression may be particularly relevant
in exploring pharmacological options for the clinical treatment of
aggressive and impulsive disorders. Objectives: To investigate and
compare the effects of a 5-HT(1B) selective agonist, CP-94,253, on
aggression that was heightened as a result of 1) social instigation or
2) alcohol treatment. Methods: Male CFW mice were administered 1.0 g/kg
EtOH and were subsequently confronted by an intruder in their home
cage. In a separate experimental procedure, resident male mice were
instigated to aggressive behavior by brief exposure to a provocative
stimulus male. To test the hypothesis that activation of the 5-HT(1B
)receptor subtype would preferentially attenuate heightened aggression,
in comparison to the moderate levels of species-typical aggressive
behaviors, the selective agonist, CP-94,253 (1.0-30 mg/kg, IP), and
antagonists to the 5-HT(1B) (GR 127935; 10 mg/kg, IP) and the 5-HT(1A)
receptor (WAY 100,635; 0.1 mg/kg IP) were used. Results: CP-94,253
suppressed non-heightened aggressive behavior (ED(50)=7.2 mg/kg ). GR
127935, but not WAY 100,635 shifted the ED(50) for CP-94,253 to 14.5
mg/kg. Importantly, the anti-aggressive effects of
CP-94,253 were not accompanied by locomotor sedation.
Alcohol-heightened and instigation-heightened aggression were
suppressed at lower doses than those necessary to suppress
non-heightened aggression (ED(50)=3. 8 and 2.7 mg/kg, respectively).
Conclusions: The current results support the hypothesis that activation
of 5-HT(1B) receptors modulates very high levels of aggressive behavior
in a pharmacologically and behaviorally specific manner.
PMID: 10550489Entrez PubMed